See what's new in this month's newsletter
- Going to AMCP Annual? Join our FormularyDecisions Lunch & Learn session – The latest innovations in digital engagement through FormularyDecisions
- Also, don't miss our Spotlight Session – Inside the mind of the payer: Understanding payer insights in a dynamic healthcare landscape
- Explore all of our other events, thought leadership sessions, and research
- Get the details on the FormularyDecisions Biopharma Innovation and Impact Awards ceremony
- Learn more about our upcoming AMCP Webinar hosted by FormularyDecisions – The Missing PIEce: Best Practices for Implementing Pre-Approval Information Exchange (PIE) in a Payer Communication Plan
- Now available: Export data from your Insights Dashboard
Attending AMCP Annual? Connect with us!
AMCP Annual (March 31 – April 3, 2024; Houston, TX)
FormularyDecisions Lunch & Learn session:
The latest innovations in digital engagement through FormularyDecisions
Date: Tuesday, April 1
Time: 12pm – 1pm CT
Location: George R. Brown Convention Center, Room 360B
Time: 12pm – 1pm CT
Location: George R. Brown Convention Center, Room 360B
Join us to gain valuable insights into optimizing your digital presence and strengthening relationships with key stakeholders.*
Key learnings:
Key learnings:
- Get updated on the latest features on FormularyDecisions
- Discover strategies for proactively sharing unapproved product dossiers with healthcare decision-makers to build early relationships and enhance engagement
- Uncover ways to amplify awareness of your product information among key stakeholders using cutting-edge digital tools and strategies
- Learn how to obtain rapid feedback from healthcare decision-makers to refine and advance your market access and evidence generation planning strategies for maximizing digital engagement with healthcare decision-makers
*Lunch will be served for attendees.
Don't miss our Spotlight Session:
Inside the mind of the payer:
Understanding payer insights in a dynamic healthcare landscape
Date: Wednesday, April 2
Time: 1:15pm – 1:30pm CT
Time: 1:15pm – 1:30pm CT
In this session, we will explore the latest trends shaping the United States payer landscape, with a focus on how payers are navigating access and formulary management within managed care organizations.
Attendees will gain valuable insights from recent studies conducted by Cencora, featuring perspectives from decision-makers at health plans, pharmacy benefit managers, and integrated delivery networks.
Key topics:
By the end of the session, participants from biopharmaceutical manufacturers and managed care organizations will have a better understanding of the current payer landscape, along with insights into anticipated challenges and opportunities in access and formulary coverage.
Attendees will gain valuable insights from recent studies conducted by Cencora, featuring perspectives from decision-makers at health plans, pharmacy benefit managers, and integrated delivery networks.
Key topics:
- Utilization of value access information in decision-making
- Market access considerations for cell and gene therapies
- Payer strategies regarding anti-obesity medications
- Insights into payer perspectives on pre-approval information exchange
By the end of the session, participants from biopharmaceutical manufacturers and managed care organizations will have a better understanding of the current payer landscape, along with insights into anticipated challenges and opportunities in access and formulary coverage.
Celebrating excellence: FormularyDecisions Biopharma Innovation and Impact Awards ceremony
Date: Tuesday, April 1
Time: 12:00pm – 12:10pm
Join us as we announce our 2025 award recipients. FormularyDecisions Innovation and Impact Awards recognize biopharma companies that have demonstrated exceptional support for healthcare decision-maker needs in formulary decision-making. It is awarded annually to distinguished recipients in 2 categories: emerging biopharma and mid-to-large biopharma.
Time: 12:00pm – 12:10pm
Join us as we announce our 2025 award recipients. FormularyDecisions Innovation and Impact Awards recognize biopharma companies that have demonstrated exceptional support for healthcare decision-maker needs in formulary decision-making. It is awarded annually to distinguished recipients in 2 categories: emerging biopharma and mid-to-large biopharma.
Fostering, engaging and supporting our healthcare decision-maker community: Payer engagement
We’ll be connecting with healthcare decision-makers during our healthcare decision-maker session, “Houston! We have a solution with FormularyDecisions,” an exclusive networking event, where they can learn more about how their colleagues are leveraging FormularyDecisions in their product review process and pre-approval information. Note: This is a closed session restricted to formulary decision-makers.
Upcoming webinar
The missing PIEce: Best practices for implementing Pre-Approval Information Exchange (PIE) in a payer communication plan
Date: Friday, March 14, 2025
Time: 2:00pm – 3:00pm ET
Join us for an interactive, engaging, and informative discussion as we dive into the evolving landscape of pre-approval information exchange (PIE). Our diverse panel of biopharma, market access, and communication experts will guide you through a live session filled with valuable insights and strategies for engaging healthcare decision-makers with pre-approval information. We will explore opportunities and innovative solutions for leveraging PIE when collaborating with stakeholders.
Time: 2:00pm – 3:00pm ET
Join us for an interactive, engaging, and informative discussion as we dive into the evolving landscape of pre-approval information exchange (PIE). Our diverse panel of biopharma, market access, and communication experts will guide you through a live session filled with valuable insights and strategies for engaging healthcare decision-makers with pre-approval information. We will explore opportunities and innovative solutions for leveraging PIE when collaborating with stakeholders.
The FormularyDecisions Biosimilar Hub is industry-recognized for excellence
We are proud to announce that the FormularyDecisions Biosimilar Hub has been recognized as a finalist in the Excellence in Engagement through Digital Channels and New Technology category at the Pharmaceutical Market Excellence Awards (PMEA). This honor highlights our commitment to excellence, best practices, and innovation. We remain dedicated to improving and innovating FormularyDecisions to streamline healthcare decision-makers’ product review process, enabling them to make informed formulary decisions for patients with confidence.
Now available: Export data from your Insights Dashboard
We’ve updated the Insights Dashboard so that you can export the underlying data from each graph into a simple Excel file, making insights easier to analyze and use.
To export data from a graph, simply click the 3 dots in the top right corner of the graph and select “Export data.” This functionality is available in both the Activity and Reviews tab of your Insights Dashboard.
Whether you’re preparing a slide deck, tracking key performance indicators, or just wanting to dig into the data for your product, the new Insights Dashboard export feature will make it easier for you to leverage your insights beyond FormularyDecisions.
Need assistance with your FormularyDecisions account?
Have a question about your subscription?
Your Subscription Engagement Team is here to assist with an array of activities—from setting up your subscription to digitizing your eDossier, providing technical support, and helping address any other questions that may arise. The FormularyDecisions Subscription Engagement Team is your personalized support backed by a broad, cross-functional team and a suite of self-service tools.
FormularyDecisions is owned and operated by Xcenda L.L.C., which is a subsidiary of Cencora, a global pharmaceutical sourcing and distribution services company.
With regard to the webinars and sessions referenced in this newsletter, FormularyDecisions strongly encourages participants to review all available information related to the topics discussed during such webinars and sessions, and to rely on their experience and expertise in making decisions related thereto.